A recent study demonstrated that high ALT levels can reduce insulin sensitivity in hepatocytes, further affect glucose levels and fat accumulation in the human body, and aggravate the occurrence and development of NAFLD [35]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.